News

News

News Alert

Dr. J. Craig Venter named to Forbes list of "100 Greatest Living Business Minds"

Timing is everything in science, like it is in most things in life. In 1944 Oswald Avery did the experiment proving DNA was how traits are inherited. But he didn't get the Nobel Prize because everybody wanted to believe proteins were the genetic material. I've been lucky. I nearly flunked out of high school, and I decided not to go to college even though I had a swimming scholarship. I ended up in Vietnam. After, I had to start my education over from scratch.

Continue Reading
News Alerts

Statement from Human Longevity Inc. on PNAS Paper on Face and other Trait Predictions from Whole Genome Sequencing and Machine Learning for Identification of Individuals

September 5, 2017 As outlined in a peer reviewed study recently published in the journal, Proceedings of the National Academy of Sciences (PNAS), Human Longevity researchers set out to see what traits could be predicted and thus used to identify individuals applying machine learning algorithms to whole genome data, without assuming any additional information such […]

Continue Reading
Press Releases

Researchers from Human Longevity, Inc. Use Whole Genome Sequence Data and Machine Learning to Identify Individuals Through Face and Other Physical Trait Prediction

(SAN DIEGO, CA)—September 5, 2017—Researchers from Human Longevity, Inc. (HLI) have published a study in which individual faces and other physical traits were predicted using whole genome sequencing data and machine learning. This work, from lead author Christoph Lippert, Ph.D. and senior author J. Craig Venter, Ph.D., was published in the journal Proceedings from the […]

Continue Reading
Press Releases

Human Longevity, Inc. Researchers Develop New Algorithm to Rapidly and Accurately Predict HLA Types Using Illumina Next Generation Sequencing Technology

(SAN DIEGO, CA)—July 3, 2017—Researchers from Human Longevity, Inc. (HLI) have developed a new algorithm called xHLA to rapidly and accurately determine the sequence of the human leukocyte antigen (HLA) gene region from 30x whole genome sequencing using Illumina HiSeq X10 and NovaSeq sequencing technology. This work was published by lead author Chao Xie, Ph.D. […]

Continue Reading
Press Releases

Human Longevity, Inc. Announces Agreement with Merck KGaA, Darmstadt, Germany to Engage in Cancer Biomarker Discovery in Advanced Melanoma

(SAN DIEGO, CA)—June 15, 2017—Human Longevity, Inc. (HLI), the genomics-powered, health intelligence company, announced today that the company has signed an agreement with Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono in the U.S. and Canada, with the goal of pioneering the application of advanced genomics and expert analysis with machine […]

Continue Reading
Press Releases

Saturnino (Nino) Fanlo Joins Human Longevity, Inc. as Chief Financial Officer

Financial Industry Leader Brings 30 Years of Experience Leading Public, Private Companies; Raising Billions in Financing Rounds (SAN DIEGO, CA)—May 25, 2017—Human Longevity, Inc. (HLI), the genomics-based, health intelligence company, announced today that Saturnino (Nino) Fanlo will be joining the company as Chief Financial Officer, reporting to CEO Cynthia Collins. Fanlo brings decades of financial […]

Continue Reading
Press Releases

Human Longevity, Inc. Launches Pilot Program, Health Nucleus X

Offering Includes Whole Genome Sequencing and Full Body MRI to Give Insight into Cancer, Cardiovascular, Metabolic and Neurological Disease Risk (SAN DIEGO, CA)—May 11, 2017—Human Longevity, Inc. (HLI), the genomics-based, health intelligence company, today announced a pilot program, Health Nucleus X (HNX) as part of the company’s Health Nucleus clinical research program, that offers individuals […]

Continue Reading
Press Releases

Human Longevity, Inc. Enhances Senior Leadership Team, Making Key Hires to Strengthen Commercialization and Operations

Travis Lacey is Chief Corporate Development Officer, Dale Gordon is Chief Commercialization Officer, Gary G. Altman, Ph.D., joins as Chief Operating Officer and Steven Ness, D.O., is Head of Client Services (SAN DIEGO, CA) May 2, 2017– Human Longevity, Inc. (HLI) the genomics-powered, health intelligence company, announced today that several new senior staff have been […]

Continue Reading
Partner Releases

The Worth Group Unveils First Health and Wellness Summit

Selects San Diego as Host Location, Announces Partnership with Human Longevity Inc. (HLI)

Continue Reading
Press Releases

Machine Learning Visionary, David Heckerman, Joins Human Longevity, Inc. as Chief Data Scientist

SAN DIEGO, CA, March 21, 2017 – Human Longevity, Inc., the genomics–powered, health intelligence company, announced today that David Heckerman, M.D., PhD., a 25-year veteran of Microsoft, has joined the company as the Chief Data Scientist. Dr. Heckerman, who will report to J. Craig Venter, Ph.D., HLI Co-founder, Executive Chairman and head of scientific strategy, […]

Continue Reading
Press Releases

Human Longevity, Inc. and MassMutual Sign Groundbreaking Agreement to Offer HLIQ™ Whole Genome Sequencing to MassMutual’s Customers, Financial Professionals and Employees

SAN DIEGO, Calif. and SPRINGFIELD, Mass. – March 15, 2017— Human Longevity, Inc. (HLI), the genomics-based, health intelligence company and Massachusetts Mutual Life Insurance Co. (MassMutual), announced today they have signed an innovative multi-year agreement to offer HLI’s whole genome sequencing product, HLIQ Whole Genome, to eligible MassMutual customers, employees and financial professionals at a […]

Continue Reading

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets